No Comments
Represent pharmaceuticals company Uman in a Hatch-Waxman action related to ANDA for a generic version of Bendamustine that Cephalon markets under the brand-name TREANDA, a treatment for chronic lymphocytic leukemia and non-Hodgkin’s lymphoma.
Categories:
